Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced the signing of an asset purchase agreement between Sanofi and Visirna Therapeutics, a majority-owned subsidiary of Arrowhead created to ...

In adults 40-75 years of age with hypertriglyceridemia and an ASCVD risk of ≥7.5%, it is reasonable (COR IIa) to address secondary causes of hypertriglyceridemia and start statin therapy.

Some health conditions can also lead to hypertriglyceridemia, some of which include cirrhosis or liver disease resulting in liver damage, hypothyroidism, hyperglycemia, and nephrotic syndrome.

Paper Published: 13 September 2005 Hypertriglyceridemia as a possible risk factor for prostate cancer L Wuermli, M Joerger, S Henz, H-P Schmid, W F Riesen, G Thomas, W Krek, T Cerny & S Gillessen ...

Severe hypertriglyceridemia is of concern because it can predispose to pancreatitis. Mild to moderate hypertriglyceridemia is often associated with a metabolic syndrome that increases the risk of ...

April 1, 2009 — Hypertriglyceridemia is common among US adults and should be treated with lifestyle change in most cases, according to the results of a study reported in the March 23 issue of ...

Among a cohort of adults with diabetes, 20% had hypertriglyceridemia — including 19.5% of those using statins — and this condition may confer greater atherosclerotic cardiovascular disease ...

Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "Hypertriglyceridemia - Pipeline Insight, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The "Hypertriglyceridemia ...

Persistent hypertriglyceridemia is linked to an increased risk for type 2 diabetes (T2D) in young adults, independent of lifestyle factors. This prospective study analyzed the data of 1,840,251 ...

MN-166 COMBAT ALS trial down to single digit required enrollment while MN-001 hypertriglyceridemia trial in type 2 diabetes patients requires final two patients. LA JOLLA, Calif., ...

Research Summary Olezarsen for Hypertriglyceridemia DOI: 10.1056/NEJMdo007514 Save ...